This project is a Natural Capital focused investment in regenerative natural health products manufactured in both NZ and AU for export to the USA.
Post-closing of the AU / US acquisition targets, Tribal Health Corp is contracted to undertake a USD5M crowdfunding campaign in the US as a share price discovery lead-in to an ASX listing
By producing a gender specific, Natural Health Product (NHP) with a history of therapeutic remedy use dating back to the 10th century as a niche product in the USD261B PA Infection Control sector of the USD4T PA health market, the products will enjoy a non-replicable FMA.
US incorporated, Tribal Health Corp targets delivery of recurring income and sustainable wealth creation from growers to investors.
This project is suited to HNW (High Net Worth) investors looking to allocate capital into the Natural Capital Sector through an investment in customary therapeutic remedies produced through environmentally supportive, regenerative agriculture from "Tribal" lands in New Zealand, Australia, Vanuatu and Papua New Guinea. An investment targeting an ASX listing as an early exit platform.
Renown malicious pathogen inhibiting, NZ manuka and kanuka tea tree plant oils from Aotearoa/NZ
A range of ingestible and topical NZ manuka and kanuka tea tree oil remedies from Aotearoa/NZ
A USD261B PA addressable market
And from Australia, a value added home hygiene disinfectant from the Bundjalung tribe.
Manuka oil was traditionally used by the ancient tribes as a women's therapeutic product, coming from a smaller tree with a much shorter life span. This said, the oil is chemically more "complex" than the warriors oil.
Kanuka oil was always the preserve of the tribal warriors', coming from a much bigger tree than the smaller manuka tree. A tree that lives up to 150 years but produces an oil comprising 2 isoprene building blocks, not 3 like manuka oil.
Copyright © 2024 Tribal Health Corp, USA - All Rights Reserved.
Powered by Tribal group - Website Builder